MD PhD, Senior adviser, National Cancer Institute and PATH, USA
Sant Cugat del Valles 08173
Dr. Silvia de Sanjosé is an MD, PhD with nearly 30 years of expertise in epidemiology of HPV and related cancers. She served as the President of the International Papillomavirus Society during 2015-2018 and has been Co-Chair of the Cape Town, Sydney and Virtual-Barcelona conferences of the IPVS. She has experience in large international studies involving HPV worldwide genotyping and has been involved in the development of HPV based screening guidelines for cervical cancer in Spain and in Catalonia. She has previously worked at the International Agency for Research on Cancer, and at the Catalan Institute of Oncology. Currently serving as Director of Women’Cancer for PATH in association with NCI. Dr. de Sanjosé leads teams working to introduce HPV molecular tests in Nicaragua, Guatemala, Honduras and El Salvador and is the PI of the NCI The AVE Network project aiming to identify a highly accurate and low cost approach to cervical cancer screening. She is an affiliated professor at the Department of Epidemiology, University of Washington.